BMW monitoring China price war for iX3 launch, sales chief says

BMW is closely monitoring intense pricing competition in China, its largest market, as it prepares to launch its new all-electric iX3 model there in the second half of 2026. This strategic focus on pricing is critical, given BMW's sales in China slumped 15.5% in the first half of 2025, making the iX3's success vital for returning to growth despite expectations of achieving margin parity with combustion engine equivalents for the model in Europe by 2026.

Analysis

BMW faces a critical juncture in China, its largest market, where a significant 15.5% sales slump in the first half of 2025 coincides with an intense EV price war. The company's strategy for a turnaround hinges on the launch of its new all-electric "Neue Klasse" platform, led by the iX3 model set for a H2 2026 release in the region. Management's cautious stance, highlighted by sales chief Jochen Goller, involves delaying the crucial China pricing decision until Q1 2026 to better assess the hyper-competitive landscape. This operational uncertainty in Asia contrasts sharply with the company's confidence in Europe, where the CFO anticipates the iX3 could achieve margin parity with its combustion engine equivalents as early as 2026. The core challenge for BMW will be to translate the promising underlying profitability of its new EV architecture into renewed growth and market share in China without succumbing to margin-eroding price pressures.

Key Decisions for Investors

• Investors should closely monitor BMW's forthcoming sales data from China, as the 15.5% first-half 2025 sales slump and the ongoing price war represent a significant headwind in the company's largest market.
• The key variable for future profitability is whether BMW must sacrifice its premium pricing for market share in China, making the Q1 2026 iX3 price announcement a critical catalyst to watch.
• While the company's ability to achieve margin parity with its new EV platform in Europe is a strong positive signal, weigh this against the significant execution risk of replicating that success in the hyper-competitive Chinese market.